Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Exosomes are small, membrane-bound extracellular vesicles (EVs) produced by most eukaryotic cells, typically ranging from 30 to 150 nanometers in diameter. They originate from the endosomal compartment of cells and are released into the extracellular environment through exocytosis. Exosomes carry a diverse array of biomolecules, including proteins, lipids, and nucleic acids, and mediate intercellular communication, influence recipient cell behavior, participate in immune responses, and serve as biomarkers for disease diagnosis. Engineered exosomes are being explored for therapeutic applications, such as drug and gene delivery.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Exosome (N/A).